LRCX three-lens brief
Evidence-based stock research on LRCX. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Analyst mean target $310.81 — 20% above current (31 analysts). · Trading at 92% of its 52-week range — near the top of the band.
- Trading at 92% of its 52-week range — near the top of the band.
- Analyst mean target $310.81 — 20% above current (31 analysts).
- Debt-to-equity of 35.3 — balance-sheet-heavy.
LRCX closed at $259.86 (+1.25%) as of 2026-05-04. Market cap: $324.97B. P/E (trailing) 49.1. Positives: analyst mean target $310.81 — 20% above current (31 analysts).. Concerns: trading at 92% of its 52-week range — near the top of the band.; debt-to-equity of 35.3 — balance-sheet-heavy.. Last quarter: Revenue $5.84B, net income $1.83B, free cash flow $4.35B.
Why three lenses on LRCX, not one.
A single reasoning model has blind spots it doesn’t know about. We examine LRCXacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/LRCX" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath LRCX brief"></iframe>